Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
Sara Nunnery, Ingrid A. Mayer
Drugs (2020) Vol. 80, Iss. 16, pp. 1685-1697
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Breast Cancer Treatments: Updates and New Challenges
Anna Burguin, Caroline Diorio, Francine Durocher
Journal of Personalized Medicine (2021) Vol. 11, Iss. 8, pp. 808-808
Open Access | Times Cited: 283
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
Federica Martorana, Gianmarco Motta, Giuliana Pavone, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 181
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 148
Oxidative stress in intervertebral disc degeneration: Molecular mechanisms, pathogenesis and treatment
Yidian Wang, Huiguang Cheng, Tao Wang, et al.
Cell Proliferation (2023) Vol. 56, Iss. 9
Open Access | Times Cited: 94
Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer
Riya Thapa, Obaid Afzal, Gaurav Gupta, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154736-154736
Closed Access | Times Cited: 79
Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy
Ge Yan, Qiyao Xiao, Jingyu Zhao, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 425-440
Closed Access | Times Cited: 50
MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
Yao Tian, Zhaohui Chen, Peng Wu, et al.
Advanced Science (2023) Vol. 10, Iss. 12
Open Access | Times Cited: 43
Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
Gaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Translational Oncology (2025) Vol. 52, pp. 102280-102280
Closed Access | Times Cited: 6
Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant
Sara M. Tolaney, Masakazu Toi, Patrick Neven, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 8, pp. 1500-1506
Open Access | Times Cited: 67
Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy
Lu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Polyphenol-Loaded Nano-carriers for Breast Cancer Therapy: A Comprehensive Review
Asif Ahmad Bhat, Gaurav Gupta, Muhammad Afzal, et al.
BioNanoScience (2024) Vol. 14, Iss. 4, pp. 4219-4237
Closed Access | Times Cited: 11
NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m5C‐dependent manner
Xuan Du, Cheng Cheng, Yi Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 962-976
Closed Access | Times Cited: 9
Delving Into lncRNA‐Mediated Regulation of Autophagy‐Associated Signaling Pathways in the Context of Breast Cancer
Chou‐Yi Hsu, Saade Abdalkareem Jasim, Pooja Bansal, et al.
Cell Biology International (2025)
Closed Access | Times Cited: 1
HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells
Belinda J. Petri, Kellianne M. Piell, Gordon C. South Whitt, et al.
Cancer Letters (2021) Vol. 518, pp. 152-168
Open Access | Times Cited: 42
microRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K/Akt pathway
Ying Zhang, Shan Li, Xiangguo Cui, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1546-1563
Closed Access | Times Cited: 19
Perfluoroalkyl substances promote breast cancer progression via ERα and GPER mediated PI3K/Akt and MAPK/Erk signaling pathways
Qianfeng Liu, Yongzhe Liu, Xiaoyu Li, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 258, pp. 114980-114980
Open Access | Times Cited: 18
Molecular mechanisms and therapeutic applications of huaier in breast cancer treatment
Ke-fei Luo, Linxi Zhou, Zi-wei Wu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer
Y. Chen, Hongyan Zhu, Yi Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116624-116624
Open Access | Times Cited: 8
Inhibitory effects of medium‐chain fatty acids on the proliferation of human breast cancer cells via suppression of Akt/mTOR pathway and modulating the Bcl‐2 family protein
P.G. Roopashree, Shilpa S. Shetty, Vijith Shetty, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 6
Closed Access | Times Cited: 6
Genetic Testing Enhances the Precision Diagnosis and Treatment of Breast Cancer
Ting-Lin Yang, Wenhui Li, Tao Huang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16607-16607
Open Access | Times Cited: 14
Prediction of breast cancer using blood microbiome and identification of foods for breast cancer prevention
Jeongshin An, Jinho Yang, Hyungju Kwon, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway
Junqi Wang, Kehu Yang, Xin Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1275-1287
Closed Access | Times Cited: 5
Therapeutic SHPRH-146aa encoded by circ-SHPRH dynamically upregulates P21 to inhibit CDKs in neuroblastoma
Saishuo Chang, Dong Ren, Li Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217120-217120
Closed Access | Times Cited: 5
The apple dihydrochalcone phloretin suppresses growth and improves chemosensitivity of breast cancer cells via inhibition of cytoprotective autophagy
Ming Chen, Vemana Gowd, Mingfu Wang, et al.
Food & Function (2020) Vol. 12, Iss. 1, pp. 177-190
Closed Access | Times Cited: 36
Page 1 - Next Page

Scroll to top